drugset / Trial / NCT01888224

Bioavailability Study of Isotretinoin Capsules 40 mg Under Fed Condition

NCT01888224

Phase 1 Completed 61 enrolled Dr. Reddy's Laboratories Limited
RandomizedCrossoverOpen-labelTreatment

Summary

To characterise the pharmacokinetic profile of sponsor's test formulation Isotretinoin Capsules 40 mg in comparison to the reference formulation Amnesteem (Containing Isotretinoin) Capsules 40 mg after single oral dose administration to healthy, normal, adult, human male subjects under fed condition.

Timeline

Start
2011-06
Primary completion
2011-06
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Isotretinoin Other / unclassified 40 mg Oral

Indications

No indication recorded.